Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Cancer
|
December 19, 2019
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial
Antroula Papakonstantinou, Alexios Matikas, Nils Olof Bengtsson, et al.
Diabetes Care
|
October 21, 2020
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
Kieran F Docherty, Pardeep S Jhund, Olof Bengtsson, et al.
Circulation. Heart Failure
|
November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?
Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
JACC. Heart Failure
|
June 15, 2023
Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction
Jawad H Butt, Kieran F Docherty, Mikhail N Kosiborod, et al.
JACC. Heart Failure
|
February 4, 2022
Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF
Kieran F Docherty, Joanne Simpson, Pardeep S Jhund, et al.
JAMA Cardiology
|
July 28, 2021
Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial
Kieran F Docherty, Pardeep S Jhund, Brian Claggett, et al.
JACC. Heart Failure
|
July 13, 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial
Scott D Solomon, Pardeep S Jhund, Brian L Claggett, et al.
European Heart Journal
|
August 27, 2021
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
James P Curtain, Kieran F Docherty, Pardeep S Jhund, et al.
JAMA Cardiology
|
February 17, 2021
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction
David D Berg, Pardeep S Jhund, Kieran F Docherty, et al.
European Journal of Heart Failure
|
February 22, 2021
Effect of dapagliflozin on anaemia in DAPA-HF
Kieran F Docherty, James P Curtain, Inder S Anand, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Cancer
|
December 19, 2019
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial
Antroula Papakonstantinou, Alexios Matikas, Nils Olof Bengtsson, et al.
Diabetes Care
|
October 21, 2020
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
Kieran F Docherty, Pardeep S Jhund, Olof Bengtsson, et al.
Circulation. Heart Failure
|
November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?
Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
JACC. Heart Failure
|
June 15, 2023
Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction
Jawad H Butt, Kieran F Docherty, Mikhail N Kosiborod, et al.
JACC. Heart Failure
|
February 4, 2022
Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF
Kieran F Docherty, Joanne Simpson, Pardeep S Jhund, et al.
JAMA Cardiology
|
July 28, 2021
Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial
Kieran F Docherty, Pardeep S Jhund, Brian Claggett, et al.
JACC. Heart Failure
|
July 13, 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial
Scott D Solomon, Pardeep S Jhund, Brian L Claggett, et al.
European Heart Journal
|
August 27, 2021
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
James P Curtain, Kieran F Docherty, Pardeep S Jhund, et al.
JAMA Cardiology
|
February 17, 2021
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction
David D Berg, Pardeep S Jhund, Kieran F Docherty, et al.
European Journal of Heart Failure
|
February 22, 2021
Effect of dapagliflozin on anaemia in DAPA-HF
Kieran F Docherty, James P Curtain, Inder S Anand, et al.
Page
of 8